Diabetes mellitus, superoxide dismutase and peroxisome proliferator activated receptor gamma polymorphisms modify the outcome of end‐stage renal disease patients of Han Chinese origin

Publisher： John Wiley & Sons Inc

E-ISSN： 1440-1797|23|2|117-125

ISSN： 1320-5358

Source： NEPHROLOGY, Vol.23, Iss.2, 2018-02, pp. : 117-125

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Deferasirox in thalassemia patients with end‐stage renal disease

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 91, Iss. 10, 2016-10 ,pp. : E456-E457

John Wiley & Sons Inc

Access to resources Recommend Favorite

A polymorphism, L162V, in the peroxisome proliferator-activated receptor α ( ) gene is associated with lower body mass index in patients with non-insulin-dependent diabetes mellitus

By Evans D.   Aberle J.   Wendt D.   Wolf A.   Beisiegel U.   Mann W.  

Journal of Molecular Medicine, Vol. 79, Iss. 4, 2001-05 ,pp. : 198-204

Springer Publishing Company

Access to resources Recommend Favorite

Peroxisome Proliferator-Activated Receptor Gamma Agonists in Kidney Disease – Future Promise, Present Fears

By  

Nephron Clin Pract, Vol. 112, Iss. 4, 2009-06 ,pp. : c230-c241

Karger

Access to resources Recommend Favorite

Peroxisome proliferator activated receptor (PPAR)-gamma concentrations in childhood obesity

By Akyürek Nesibe   Aycan Zehra   Çetinkaya Semra   Akyürek Ömer   Yilmaz Ağladioğlu Sebahat   Ertan Ülker  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 73, Iss. 4, 2013-06 ,pp. : 355-360

Informa Healthcare

Access to resources Recommend Favorite

Rehabilitation Outcome of Older Patients with End‐Stage Renal Disease and Lower Extremity Amputation

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 41, Iss. 6, 1993-06 ,pp. : 667-668

John Wiley & Sons Inc

Access to resources Recommend Favorite